Carb-X

Live Webinar: CARB-X 2019 Funding Rounds
2019-05-16 09:00 - 10:00 (America/New_York) | Webinar, 765 Commonwealth Avenue, Boston, MA, 02215, United States
Kevin Outterson, CARB-X Executive Director, and Karen Gallant, CARB-X Global R&D Project Director, present details of CARB-X’s four new funding rounds announced April 30, 2019, and answer questions during this webinar. To attend the live webinar, please register by clicking the link below. A recording of the webinar will be available for viewing shortly after the event. The recording will be available on the CARB-X website in the Apply > What CARB-X funds section.
Please click here to register.

GARDP Mining Chemical Libraries for New Antibacterials
2019-05-21 17:00 - 18:30 (Europe/Helsinki) | Webinar, 765 Commonwealth Avenue, Boston, MA, 02215, United States
Despite the promise of target-based drug discovery ushered in by the genomics era, no mechanistically novel rationally designed antibiotic has reached clinically utility to address the threat of multi-drug resistant bacterial pathogens. Phenotypic screening remains the primary source for new antibacterial compounds, which mainly come from mining various chemical libraries. In this webinar, Carl Balibar (Merck Research Laboratories) will discuss screen design, target bias, and hit-prioritization strategies to identify those entities with the greatest opportunity to be developed into the next new antibiotic.
The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development for various kinds of antibacterial products. In this third webinar, we will discuss the development of antibacterial drug enhancer combinations and non-traditional products.
Please note, this webinar has been rescheduled from April 4th to May 21st, 2019.
The webinar will be held from 5:00 pm – 6:30 pm CEST / 11:00 pm – 12:30 pm EDT.
The presentation will be followed by a Q&A session.
Register here for this live webinar.

Global AMR R&D Hub “Increasing Investments for AMR R&D” Workshop
2019-05-28 | Domaine de Penthes, Chemin de l'Impératrice 18, Pregny-Chambésy, 1292, Switzerland
Participants include Kevin Outterson, Executive Director of CARB-X.
The Global AMR R&D Hub is pleased to announce a one-day workshop on “Increasing Investments
for AMR R&D”, which will take place on Tuesday May 28 2019 in Geneva, Switzerland. The event
will gather representatives from governments, funders, industry, investors and other stakeholders
interested in the field of antimicrobial resistance.
Antimicrobial resistance (AMR) represents an urgent major global health threat. Currently, there is
an insufficient number of treatments and tools in the AMR research and development (R&D)
pipeline to tackle this issue. Building on ongoing initiatives, increasing investments across the One
Health spectrum is required. In particular, more effort is needed in the animal and plant fields as
well as applicability in low- and middle-income countries (LMIC).
This workshop aims to discuss investments and financing mechanisms for AMR R&D and provide
recommendations for funders and investors on how to address the vital issue of increasing
investments in AMR R&D in a One Health context that also considers applicability in LMIC.
Please click here to learn more.

CARB-X Presentation: 2019 Funding Rounds
2019-05-31 10:00 - 11:45 (America/New_York) | North Carolina Biotechnology Center, 15 T.W. Alexander Drive, Research Triangle Park, NC, 27709-3547, United States
Presentation by Karen Gallant, CARB-X Acting R&D Chief/Deputy Director. Attendees include Richard Alm, CARB-X Alliance Director.
Please join NCBiotech and RTI International as we host CARB-X Global R&D Project Director Karen Gallant for an informational session about CARB-X and the upcoming funding rounds. Karen will provide an overview of the CARB-X initiative and leave plenty of time to get all questions answered. This event is FREE to attend.
For further information, please refer to the CARB-X press release and website.

Agenda
10:00 a.m. – Presentation by Karen Gallant, Global R&D Project Director, CARB-X
10:30 a.m. – Presentation: RTI International as a CARB-X Accelerator
10:45 a.m. – Q&A Session
11:15 a.m. – Networking
11:45 a.m. – Adjourn

Registration
There is some availability for a few companies to have one-on-one meetings with CARB-X. If you are interested, please select that option on the registration page.

2019 BIO International Convention
2019-06-03 - 2019-06-06 | Philadelphia Convention Center, 1101 Arch Street, Philadelphia, PA, 19107, United States
The BIO International Convention (BIO) attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. BIO brings together a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.
The key benefits of attending the 2019 BIO International Convention are access to global biotech and pharma leaders via BIO One-on-One Partnering, exposure to industry thought-leaders with over 500 education sessions at your fingertips, and unparalleled networking opportunities with 16,000+ attendees from 67 countries.
See the schedule here.

Live Webinar: GARDP/REVIVE Mining Chemical Libraries for New Antibacterials - Session 2
2019-06-04 13:30 - 15:00 (Europe/Berlin) | Boston University School of Law, 765 Commonwealth Avenue, Boston, MA, 02215, United States
The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development for various kinds of antibacterial products.
In this webinar the recording of Carl Balibar’s presentation ‘Mining of chemical libraries for new antibacterials’ (original webinar on 21 May) will be followed by another live Q&A session with Carl.
Despite the promise of target-based drug discovery ushered in by the genomics era, no mechanistically novel rationally designed antibiotic has reached clinically utility to address the threat of multi-drug resistant bacterial pathogens. Phenotypic screening remains the primary source for new antibacterial compounds, which mainly come from mining various chemical libraries. In this webinar, Carl Balibar (Merck Research Laboratories) will discuss screen design, target bias, and hit-prioritization strategies to identify those entities with the greatest opportunity to be developed into the next new antibiotic.
Speakers:
Carl Balibar, Principal Scientist, Merck Research Laboratories
Moderator:
Benjamin Blasco, Discovery Senior Project Manager, GARDP
Register here for this live webinar.

Medical, Biomedical & Biodefense: Support to the Warfighter Symposium
2019-06-05 - 2019-06-06 | The Friday Conference Center, 100 Friday Center Drive, Chapel Hill, NC, 27599, United States
Panelists members include Kevin Outterson, Executive Director of CARB-X, on the “Public-Private Partnerships: Research and Development Consortia and Accelerators” panel.

This panel will discuss the use of public-private partnerships as models for stimulating innovation through sponsored research and development. The panelists will provide overviews of several partnership-enabled consortia and accelerators, including BARDA’s new Division of Research, Innovation, and Ventures and their participation in the partnership, Combating Antibiotic Resistant Bacteria, and, as well as DoD’s Medical CBRN Defense Consortium and Medical Technology Enterprise Consortium. Presenters will discuss their organization’s background and structure, as well as their unique mechanisms for engaging the research community to solve significant public health and biomedical challenges.

The Symposium will focus on two separate tracts. The first, “Medical Support to the Warfighter,” will connect businesses and university researchers with military and other federal agencies that require or purchase medical supplies, equipment, devices, pharmaceuticals, information technology and services, or fund medical-related research and development.
The second tract, “Biomedical and Biodefense Support to the Warfighter,” will focus on establishing dialogue between industry and academia-based technology innovators and military and government officials to address the future biomedical and biodefense needs of the military and our nation.

To learn more, please click here.

Live Webinar: Funding Opportunities for Antimicrobial Drug Development from the Cystic Fibrosis Foundation
2019-06-11 10:00 - 11:00 (America/New_York) | Boston University School of Law, 765 Commonwealth Avenue, Boston, MA, 02215, United States
Interested in new funding opportunities for infection drug development?
The Cystic Fibrosis Foundation (CFF) has teamed up with CARB-X to host a live webinar on June 11, from 10:00am – 11:00am ET, to introduce their new Infection Research Initiative.
During the webinar, Dr. Ann Field, Senior Director of Drug Discovery and Development at the Cystic Fibrosis Foundation, will discuss potential funding opportunities for therapeutic development of anti-infectives in key organisms of interest for CF infections. The presentation will be followed by an interactive Q&A session.
Webinar Summary
Learn about funding opportunities for infection drug development through the Cystic Fibrosis Foundation. This webinar will include:

Overview of the CF Foundation and the recently announced Infection Research Initiative
CF Foundation interest in supporting therapeutic development for anti-infectives in key organisms of interest for CF infections
Therapeutic Development Award Process and collaboration opportunities

To join this webinar, please register here.
If you have questions or comments, please let us know. Feel free to email your questions or comments to Raj Shetty at dshetty@carbx.org before the webinar, or save them for the live Q&A session following the presentation. We look forward to hearing from you!

Live Webinar: GARDP/REVIVE Models for antimicrobial R&D: Development and use of in vivo models for infectious disease research
2019-06-11 17:00 - 18:30 (Europe/Berlin) | Boston University School of Law, 765 Commonwealth Avenue, Boston, MA, 02215, United States
The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development for various kinds of antibacterial products.
In this webinar, William J. Weiss, Director, PreClinical Services, University of North Texas System College of Pharmacy, will introduce experimental design of animal models for antimicrobial research. He will discuss questions such as 1) Where to start and what model to use? 2) Are animal models of bacterial infection reflective of the clinical condition? 3) Are in vivo animal model results predictive of clinical efficacy? The presentation will be followed by a Q&A session moderated by Peter Warn, Senior Vice President, Anti-infective Discovery, Evotec.
Speakers:
William J. Weiss, Director, PreClinical Services, University of North Texas System College of Pharmacy
Moderator:
Peter Warn, Senior Vice President, Anti-infective Discovery, Evotec
Register here for this live webinar.

ASM Microbe 2019
2019-06-20 - 2019-06-24 | Moscone Center, 747 Howard Street, San Francisco, CA, 94103, United States
Each day at ASM Microbe 2019 offers you the chance to delve into your scientific interest and specialties, discover cutting-edge research in the poster and oral presentations, and connect with a world of microbiology experts. View the ASM Microbe 2019 Schedule at a Glance for a preliminary peek at what is in store for you.

ASM Microbe Breakout Session - Enabling Academia to Fill the Discovery Gap
2019-06-24 07:15 - 08:15 (America/Los_Angeles) | Moscone Center, 747 Howard Street, San Francisco, CA, 94103, United States
Presentations developed in cooperation with GARDP, CARB-X, and REPAIR Impact Fund.
Antimicrobial resistance (AMR) continues to be a major problem that is not being addressed adequately by the pharmaceutical industry. Academic research is more frequently serving as a source for novel antimicrobial agents to treat infections caused by antibiotic-resistant organisms. In this session, drug discovery efforts originating from academic laboratories will be discussed. The importance of collaborative efforts will be emphasized.

International Council of Academies of Engineering and Technological Sciences (CAETS) Conference
2019-06-25 - 2019-06-28 | Stockholm, Stockholm, Sweden
Speakers include Kevin Outterson, Executive Director of CARB-X.
The Royal Swedish Academy of Engineering Sciences (IVA) is hosting the yearly conference for the International Council of Academies of Engineering and Technological Sciences (CAETS) in 2019. CAETS in a independent non-political, non-governmental international organization of engineering and technological science academies worldwide. The conference will focus on what engineering and technological science has accomplished in the last 100 years as well as future challenges, focusing on the topics of Health, Energy, Affordable Living, Superintelligens and Distrubution of Resources. The conference will focus on how engineering and technological science can morph into the future and contribute to solutions.

Live Webinar: GARDP/REVIVE - Find out how GARDP is redoubling its efforts to accelerate the development and delivery of new and improved antibiotics
2019-06-26 10:30 - 11:30 (America/New_York) | Boston University School of Law, 765 Commonwealth Avenue, Boston, MA, 02215, United States
In this webinar, Dr Manica Balasegaram, GARDP’s Executive Director will highlight GARDP’s role in accelerating the implementation of WHO’s Global Action Plan, and share GARDP’s updated strategy. Following his presentation, you will have the opportunity to ask questions in a Q&A session moderated by Jennifer Katz, GARDP’s Director of External Affairs.
Register here for this live webinar.

Institut Pasteur Financing Start-Ups in Life Sciences Workshop
2019-07-05
Additional Details Forthcoming.

Live Webinar: GARDP/REVIVE Infection models for antimicrobial R&D: Intracellular models
2019-07-09 11:00 - 12:30 (America/New_York) | Boston University School of Law, 765 Commonwealth Avenue, Boston, MA, 02215, United States
The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development for various kinds of antibacterial products.
In this webinar, Françoise van Bambeke, Research Director Cellular and Molecular Pharmacology, Louvain Drug Research Institute, Catholic University of Louvain (FR), will talk about intracellular activity of antibiotics. Topics discussed will include:

The role of intracellular survival in chronic infections and its contribution to poor response to antibiotics
In vitro models to study intracellular activity of antibiotics
Cellular pharmacokinetic (PK) parameters predictive of intracellular potency for antibiotics
Cellular pharmacodynamics (PD) parameters predictive of intracellular efficacy for antibiotics

The presentation will be followed by a Q&A session
Speakers:
Françoise van Bambeke, Research Director Cellular and Molecular Pharmacology, Louvain Drug Research Institute, Catholic University of Louvain (FR)
Moderator:
Laura Piddock, Director of Scientific Affairs, GARDP
Register here for this live webinar.

Deadline to submit updates to the World Health Organization clinical antibacterial pipeline
2019-07-22 08:00 - 17:00 (America/New_York) | CARB-X, 765 Commonwealth Ave, Boston, MA, 02215, United States
Please share any pipeline additions and changes that you are aware of by 22 July 2019. Download and use this form to provide updates. The latest pipeline update (as of July 1, 2018), can be found as a manuscript (Theuretzbacher et al. Lancet ID 2018), and as a set of summary tables. Contact Sarah Paulin (paulins@who.int).

The Role of NIH in Drug Development Innovation and its Impact on Patient Access: A workshop
2019-07-24 - 2019-07-25 | The National Academies Keck Building, 500 5th Street NW, Washington, DC, 20001, United States
This is an open session hosted by the National Academy of Sciences, Engineering, and Medicine. The 1.5-day public workshop to will be held on July 24-25, 2019 in Washington, D.C and focus on the translation of federal investments in biomedical science to innovation in drug development and how the public benefits from that investment in terms of drug pricing and access. The meeting will feature invited presentations and panel discussions on topics that may include:

how federal funding for biomedical research, particularly via NIH, has contributed to new drug development, both directly and indirectly
the pricing of drugs that have benefited from federal investments in biomedical science;
the role of technology and patent transfer to and from entrepreneurial organizations associated with NIH-funded research
potential ways to better track, quantify, and document NIH contributions to innovation in drug development
potential strategies and policies to facilitate the translation of federally-funded biomedical research into innovations in drug development and to help ensure that the public has affordable access to those innovative medicines.
The planning committee will develop the agenda, select and invite subject matter experts and discussants, and moderate the discussions. A proceedings of the event will be prepared in accordance with institutional guidelines.

To learn more, click here.

UK Medical Research Council National PhD Training Programme in AMR - Annual Conference
2019-08-12 08:00 - 2019-08-13 17:00 (America/New_York) | University of Bristol, Bristol, BS8 1TD, United Kingdom
Keynote lecture given by Kevin Outterson, Executive Director of CARB-X.
Additional details forthcoming.

Live Webinar: GARDP/REVIVE - Models for antimicrobial R&D: Computational modelling for population PK and PKPD
2019-08-20 11:00 - 12:30 (America/New_York) | Webinar, 765 Commonwealth Avenue, Boston, MA, 02215, United States
The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development for various kinds of antibacterial products.
In this webinar, Lena Friberg and Elisabet Nielsen (Department of Pharmaceutical Biosciences, Uppsala University, Sweden), will discuss:

Population PK modelling to characterize drug exposure and variability
PKPD-modelling to characterize preclinical time-kill data
PKPD-modelling for translation to patients
Model-based dose-individualization

The presentation will be followed by a Q&A session.

Speakers:
Lena Friberg and Elisabet Nielsen, Department of Pharmaceutical Biosciences, Uppsala University, Sweden
Moderator:
Ursula Theuretzbacher, Center for Anti-Infective Agents, Vienna, Austria
Register here for this live webinar.

Annual ASM/ESCMID Conference on Antibiotic Development to Meet the Challenge of AMR
2019-09-03 - 2019-09-06 | Boston, Venue Forthcoming, Boston, MA, United States
The ASM/ECSMID Conference on Drug Development returns to Boston, Massachusetts for 2019. Check back soon for program details.
Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by National and International bodies. There are relatively few agents in developmental pipelines and a paucity of identified microbiological targets that can be exploited for drug development. Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will address the challenges, opportunities and current requirements for antimicrobial drug development for AMR.

Harvard Museum of Natural History Reception and Mixer
2019-09-04 18:30 - 21:00 (America/New_York) | Harvard Campus, 52 Oxford Street, Cambridge, MA, 02138, United States
Sponsored by the Harvard Microbial Sciences Initiative and the Boston Area Antimicrobial Research Network

Drinks, hors d’oeuvres, and exclusive private access to the Harvard Museum of Natural History https://hmnh.harvard.edu/. This is a chance to unwind with fellow attendees at the ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance, and meet those from the Harvard University Microbial Sciences Initiative and Boston Area Antimicrobial Resistance Network sharing that interest. The museum is the quintessential university natural history museum with many unique and historical collections and displays, located on the main Cambridge campus of Harvard University.
SPACE IS LIMITED to the first 150 to RSVP.
To reserve your place – reply to: michael_gilmore@meei.harvard.edu. Copy the subject line I WILL ATTEND, and provide your name, affiliation and email. You will be provided a map, directions and an ENTRY TICKET in response.

5th ESCMID Conference on Vaccines
2019-09-06 - 2019-09-08 | Bilbao – Spain, Bilbao, Spain
Online registration will open in spring 2019 – Check back soon for details.

CeBIL Annual Symposium 2019: Legal Innovation to Support the Development of Antimicrobial Drugs
2019-09-06 08:15 - 18:00 (Europe/London) | Christ’s College Cambridge, St. Andrew's Street, Cambridge, CB2 3BU, United Kingdom
This symposium explores the complex interactions between law and antimicrobial research and development. Advancing our understanding of this ecosystem will help design a better legal toolkit to promote antimicrobial innovation and limit the impact of resistance on global health.
Held at the University of Cambridge, an international hub for legal and scientific expertise, we hope the event will mobilize legal, economic, business, medical and scientific experts – early, mid, and late career – who recognize the need to work together to avert the AMR crisis.
Click here to learn more.
Click here to register.

CARB-X Product Developer Conference
2019-09-06 12:00 - 18:00 (America/New_York) | Boston, Venue Forthcoming
We are excited to announce that CARB-X will be hosting our first ever CARB-X Developer Conference. The conference will be held on September 6th, 2019 in Boston, immediately following the conclusion of the ASM-ESCMID conference. Additional details will follow. Please save the date!

This will be an excellent networking event for CARB-X product developers, who will have the opportunity to connect with and learn from some of the most innovative members of the AMR community, including companies in our diverse portfolio as well as representatives from our expanded accelerator network.
If applicable, please feel free to use your CARB-X travel budget to fund attendance for up to three members of your team. Allowable incurred travel costs will be reimbursed after the meeting via the standard CARB-X invoicing process. Please click here for further travel guidance, and if you have any additional questions please reach out to your CARB-X Finance and Grants Manager for clarity.
We will follow up soon with additional details for the CARB-X Product Developer Conference. Please forward this save-the-date to those interested on your team, including principle investigators, science leads, and project managers. Please contact Dhanuraj Shetty at dshetty@bu.edu with any urgent questions or concerns.
Mark your calendars and join us on September 6th, 2019!

Institut Pasteur Financing Start-Up Breakfast
2019-09-10

Live Webinar: GARDP/REVIVE – Models for antimicrobial R&D: Advanced and complex in vivo models for infectious disease research
2019-09-10 11:00 - 12:30 (America/New_York) | Webinar, 765 Commonwealth Avenue, Boston, MA, 02215, United States
In this webinar, Peter Warn will review the experimental design and conduct of advanced or complex animal models for antimicrobial research.
This webinar is designed as a follow on from the webinar of William J. Weiss: Models for antimicrobial R&D: Development and use of in vivo models for infectious disease research (see here: http://bit.ly/2ZiPt6y).
Topics covered in this webinar will include:

In depth review of animal models of pneumonia, UTI and tissue infections including biofilm models.
Animal models of non-traditional drugs where CFU might not be a suitable biomarker.
Tips, hints and pitfalls when trying to generate informative data in PKPD studies.

The presentation will be followed by a Q&A session.

Speaker:
Peter Warn, Senior Vice President, Anti-infective Discovery, Evotec
Moderator:
William J. Weiss, Director, PreClinical Services, University of North Texas System College of Pharmacy
Register here for this live webinar.

AMR Challenge: A Night Celebrating Global AMR Fighters
2019-09-23 18:00 - 21:00 (America/New_York) | Cipriani Midtown, 110 E. 42nd Street, New York City, NY, 10017, United States
Join HHS Secretary, Alex Azar, experts from the U.S. Centers for Disease Control and Prevention, and hundreds of organizational and global leaders for an evening celebrating the culmination of the AMR Challenge at an unofficial side event of the 74th United Nations General Assembly in New York City.

IDWeek 2019 Annual Conference
2019-10-02 - 2019-10-06 | Walter E. Washington Convention Center, 801 Mount Vernon Pl. NW,, Washington D.C., DC, 20001, United States
Attendees include Richard Alm, CARB-X Alliance Director.
IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medical Association (HIVMA), and the Pediatric Infectious Diseases Society (PIDS).
At IDWeek, you will see familiar colleagues and new faces. IDWeek is a forum for health professionals of varied backgrounds to collaborate, cooperate, and learn from each other’s expertise. With so many common issues and challenges cutting across our four disciplines, IDWeek provides an opportunity to learn from each other’s knowledge, experience and expertise, for the improvement of patient care and public health.
This is an inclusive meeting that offers access to internationally recognized leaders in the field and the opportunity to network with the most highly respected health professionals in infectious diseases, including HIV.
To learn more, click here.
To view the program, click here.
To register for the conference, click here.

Live Webinar: GARDP/REVIVE – Natural products antibiotics: from traditional screening to novel discovery approaches
2019-10-03 11:00 - 12:30 (America/New_York) | Webinar, 765 Commonwealth Avenue, Boston, MA, 02215, United States
In this webinar, Olga Genilloud will discuss the role of natural products in current antibiotic discovery. Topics discussed will include:

Screening strategies to identify novel antibiotics
Current challenges and novel analytical tools
New omic approaches supporting antibiotic discovery

The presentation will be followed by a Q&A session.

Speaker:
Olga Genilloud, Scientific Director, Fundación MEDINA, Granada, Spain
Moderator:
Laura Piddock, Director of Scientific Affairs, GARDP
Register here for this live webinar.

Live Webcast: Drug-Resistant Infections: Confronting an Escalating Crisis
2019-10-11 12:00 - 13:00 (America/New_York) | Webinar, 765 Commonwealth Avenue, Boston, MA, 02215, United States
Antibiotics are a pillar of modern medicine. They have saved millions of lives and added some 20 years to human life expectancy. But as the use of antibiotics has increased, so has the proliferation of antibiotic-resistant microbes that have adapted to survive most, or all, of today’s antibiotics. The CDC reports that two million people are infected with drug-resistant bacteria every year in the United States, and the Review on Antimicrobial Resistance estimated that, around the world, 700,000 people die of such infections annually. That number stands to increase: the Review predicts that, by 2050, drug resistance could be responsible for 10 million deaths a year. And while these numbers are dominated by bacterial infections, fungal infections like Candida auris are also a threat, especially to vulnerable patients in hospitals and nursing homes.
Despite drug resistance growing, the development of new antibiotics has slowed. How can policymakers help accelerate the pace of new drug development. How can all of us—doctors, hospitals, and patients, as well as the agricultural sector—be better stewards of existing drugs? Forum panelists will examine the scope of this looming crisis and look at how changes in policy and practice can help us stay one step ahead of these superbugs.
Moderator
David Freeman, Editorial Director of NBC News MACH
Panelists
Helen Boucher, Director, Tufts Center for Integrated Management of Antimicrobial Resistance (CIMAR) and Professor of Medicine at Tufts University School of Medicine
Lauri Hicks, Director, Office of Antibiotic Stewardship, Centers for Disease Control and Prevention
Marc Lipsitch, Professor of Epidemiology and Director of the Center for Communicable Disease Dynamics at the Harvard T.H. Chan School of Public Health
Kevin Outterson, Executive Director of CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator), and Professor of Law, Boston University
Part of: The Dr. Lawrence H. and Roberta Cohn Forums.
Presented jointly with NBC News Digital
Live webcast will be on Friday, October 11, 2019, 12:00pm – 1:00pm ET.
An on-demand video will be posted after the event.
To learn more, click here.
